Lofexidine in the treatment of hypertension: a twice-daily versus one-daily dose comparison with 24-hour blood pressure monitoring

Lofexidine, an antihypertensive imidazoline derivative, was given to ten hypertensives on both a twice-daily and once-daily regimen, using routine blood pressure measurements and 24-hour Remler recording. Plasma renin activity and catecholamines were measured. After a dose titration with twice-daily doses, the total twice-daily dose was given once daily for two weeks and the drug abruptly withdrawn. Mean placebo blood pressure was 136/104 mm Hg supine. After twice-daily therapy, this fell to 118/86 mm Hg, and upon conversion to once-daily therapy, it rose to 126/89 mm Hg. With the Remler recorder, mean 24-hour blood pressure was 125/89 during the twice-daily therapy, 133/94 mm Hg during once-daily therapy, and 142/99 mm Hg on the day after acute withdrawal; i.e., evaluation in all three treatment periods showed a lack of sustained control with both a wide range and high frequency of blood pressure variation. Plasma renin activity and plasma epinephrine and norepinephrine did not change significantly during the study.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. I. M. Drayer, M. A. Weber, and W. J. Hoeger Whole-Day BP Monitoring in Ambulatory Normotensive Men Arch Intern Med, February 1, 1985; 145(2): 271 - 274. [Abstract] [PDF]

				J. I. M. Drayer, M. A. Weber, J. L. DeYoung, and D. D. Brewer Long-term BP Monitoring in the Evaluation of Antihypertensive Therapy Arch Intern Med, May 1, 1983; 143(5): 898 - 901. [Abstract] [PDF]